Christopher Ryan Sullivan - May 15, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Financial Officer
Signature
/s/ Jennifer Zoltoski, by Power of Attorney
Stock symbol
AVTX
Transactions as of
May 15, 2023
Transactions value $
$0
Form type
4
Date filed
5/17/2023, 07:44 AM
Previous filing
Feb 15, 2023
Next filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +40K $0.00 40K May 15, 2023 Common Stock 40K $2.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in full on May 15, 2024, subject to the Reporting Person's continued service on such vesting date.